Summary: | Background : Nosocomial pneumonia or commonly called as well with hospitalacquired
pneumonia (HAP) placed second most common nosocomial infection
after urinary tract infection. Pneumonia can occur when stomach contents or
enteral nutrition experiencing regurgitation then aspirated. The use of Nasogastric
Tube increasingly recognized as a risk factor for nosocomial pneumonia.
Nasogastric tube may increase oropharyngeal colonization, reflux, and bacterial
migration.
Objective : To determine the relationship between the use of NGT on the
incidence of nosocomial pneumonia in hospitalized patients.
Methods: An observational study with a cohort approach. A total of 24 patients
divided into 2 groups: the treatment group and the control group. Treatment group
were patients who use the NGT, whereas the control group were responders
without NGT, we follow-up since admission to the home to see the incidence of
nosocomial pneumonia. Statistical analysis of the data using the Fisher Exact (CI
95%, �=0.05)
Result : the incidence of nosocomial pneumonia in the treatment group as much
as 4 cases (33.3%), and the incidence of pneumonia nosocomial was not found in
the control group (0%). p = 0.093, CI = 0.447 to 0.995. Test results to determine
the effects of treatment results showed RR = 0.667.
Conclusion : No statistically significant relationship between the use of NGT
with the incidence of nosocomial pneumonia, but there is a clinically meaningful
relationship.
|